Patient Guide: A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 15 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06735248
Status: 🟢 Enrolling Now
Condition: Multiple Sclerosis
Phase: PHASE2

Where You Can Participate

This study is available at 15 locations across the country.

Top locations include:
  • • Boston, Massachusetts
  • • Farmington Hills, Michigan
  • • St Louis, Missouri
  • • And 12 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years - Join Clinical Trial NCTNCT06735248

How to Join This Clinical Trial - NCTNCT06735248

Learn how to participate in this PHASE2 trial studying an investigational therapy for Multiple Sclerosis. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Multiple Sclerosis. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Multiple Sclerosis
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06735248 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 15 locations. Find a study site near you:

Clinical Research Site

Boston, Massachusetts 02131 - United States

Status: RECRUITING

Clinical Research Site

Farmington Hills, Michigan 48334 - United States

Status: RECRUITING

Clinical Research Site

St Louis, Missouri 63110 - United States

Status: RECRUITING

Clinical Research Site

Oklahoma City, Oklahoma 73104 - United States

Status: RECRUITING

Clinical Research Site

Dallas, Texas 75390-8806 - United States

Status: RECRUITING

Clinical Research Site

El Paso, Texas 79912 - United States

Status: RECRUITING

Clinical Research Site

Birtinya, Queensland 04575 - Australia

Status: RECRUITING

Clinical Research Site

Bristol, BS10 5NB - United Kingdom

Status: RECRUITING

Clinical Research Site

Cardiff, CF14 4XW - United Kingdom

Status: RECRUITING

Clinical Research Site

Edinburgh, EH16 4SB - United Kingdom

Status: RECRUITING

And 5 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Multiple Sclerosis:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships